Replies to post #155930 on Biotech Values

[mcbio]

I dont even know if they talk about this compound in their presentations.

Yeah, more immediate focus is clearly the PI3K. May suggest that Bcl-2 not quite ready for the clinic. Maybe it's a 2014 event. Still, sounds like a promising target and sounds like it may get at CSCs.